Search results
Johnson & Johnson (NYSE:JNJ) Shares Sold by Tandem Investment Advisors Inc.
ETF DAILY NEWS· 6 days agoTandem Investment Advisors Inc. reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1.6% in the 4th quarter, according to its most recent disclosure with the Securities ...
Johnson & Johnson (NYSE:JNJ) Shares Acquired by Pathway Financial Advisors LLC
ETF DAILY NEWS· 4 days agoPathway Financial Advisors LLC lifted its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.3% in the 4th quarter, according to its most recent disclosure with the Securities ...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 7 days agoOctober 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
Johnson & Johnson (NYSE:JNJ) Shares Acquired by Archer Investment Corp
ETF DAILY NEWS· 7 days agoArcher Investment Corp increased its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange ...
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
Fox News via Yahoo News· 5 days agoMissouri Sen. Josh Hawley is pushing to expand payments to those exposed to Manhattan Project...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 4 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 6 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 2 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
Morningstar· 12 hours agoNEW YORK, April 29, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering